1887

Abstract

Summary

Interferon (IFN) production following exposure to Epstein–Barr virus (EBV) was studied in primary human mononuclear leukocytes. When the leukocytes were exposed to EBV (strain B95-8 or P3HR-1) the IFN level reached a maximum 24 h after exposure to the virus, and a gradual decrease followed. A linear relationship was obtained between the input dose of EBV and the IFN titre. The IFN inducibility of leukocytes did not correlate with the EBV infectibility. IFN was also induced by u.v.-inactivated EBV and heat-inactivated EBV, but not by neutralized virus. IFN inducibility varied among adult donors, but there was no significant difference between EBV-seropositive and -seronegative groups. The response of cord blood leukocytes, however, was lower than that of the cells from adults. The activity of all IFN samples in this study was stable to acid and heat and exclusively neutralized by anti-human IFN-. B cells, T cells and NK cells all produced IFN in response to EBV, but monocytes did not.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-4-837
1984-04-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/4/JV0650040837.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-4-837&mimeType=html&fmt=ahah

References

  1. Adams A., Strander H., Cantell K. 1975a; Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. Journal of General Virology 28:207–217
    [Google Scholar]
  2. Adams A., Lidin B., Strander H., Cantell K. 1975b; Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines. Journal of General Virology 28:219–223
    [Google Scholar]
  3. Armstrong J. A. 1971; Semi-micro, dye-binding assay for rabbit interferon. Applied Microbiology 21:723–725
    [Google Scholar]
  4. Aya T., Osato T., Kishida T. 1980; Protection against Epstein-Barr virus oncogenesis. Cooperative effect of lymphocytes, antibodies and interferon. Proceedings of the Japan Academy 56:523–527
    [Google Scholar]
  5. Biron C. A., Hutt-Fletcher L. M., Wertz G. T., Pagano J. S. 1981; Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitro. International Journal of Cancer 27:185–190
    [Google Scholar]
  6. Doetsch P. W., Suhadolnik R. J., Sawada Y., Mosca J. D., Flick M. B., Reichenbach N. L., Dang A. Q., Wu J. M., Charubala R., Pfleiderer W., Henderson E. E. 1981; Core (2′–5′) oligoadenylate and the cordycepin analog: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes in the absence of interferon. Proceedings of the National Academy of Sciences, U. S. A 78:6699–6703
    [Google Scholar]
  7. Dolyniuk M., Pritchett R., Kieff E. 1976; Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. Journal of Virology 17:935–949
    [Google Scholar]
  8. Epstein M. A., Achong B. G. (editors) 1979 The Epstein-Barr Virus Berlin: Springer-Verlag;
    [Google Scholar]
  9. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R. Jr, Grace J. T. Jr 1967; Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. Journal of Virology 1:1045–1051
    [Google Scholar]
  10. Lai P. K., Alpers M. P., Mackay-Scollay E. M. 1977; Epstein-Barr herpesvirus infection: inhibition by immunologically induced mediators with interferon-like properties. International Journal of Cancer 20:21–29
    [Google Scholar]
  11. Lvovsky E., Levine P. H., Fuccillo D., Ablashi D. V., Bengali Z. H., Armstrong G. R., Levy H. B. 1981; Epstein-Barr virus and herpesvirus saimiri: sensitivity to interferons and interferon inducers. Journal of the National Cancer Institute 66:1013–1019
    [Google Scholar]
  12. Menezes J., Patel P., Dussault H., Joncas J. 1976; Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein-Barr virus. Nature, London 260:430–432
    [Google Scholar]
  13. Miller G., Lipman M. 1973; Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, U. S. A 70:190–194
    [Google Scholar]
  14. Nonoyama M., Pagano J. S. 1973; Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature, London 242:44–47
    [Google Scholar]
  15. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein-Barr virus (EBV)-associated complementfixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
  16. Rickinson A. B., Wallace L. E., Epstein M. A. 1980; HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature, London 283:865–867
    [Google Scholar]
  17. Slovin S. F., Schooley R. T., Thorley-Lawson D. A. 1983; Analysis of cellular immune response to EBV by using cloned T cell lines. Journal of Immunology 130:2127–2132
    [Google Scholar]
  18. Swart B. E., Young B. G. 1969; Inverse relationship of interferon production and virus content in cell lines from Burkitt’s lymphoma and acute leukemias. Journal of the National Cancer Institute 42:941–944
    [Google Scholar]
  19. Takada K., Osato T. 1982; Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection. Intervirology 18:87–91
    [Google Scholar]
  20. Thorley-Lawson D. A. 1981; The transformation of adult but not newborn human lymphocytes by Epstein-Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein-Barr infection is mediated by interferon. Journal of Immunology 126:829–833
    [Google Scholar]
  21. Zajac B. A., Henle W., Henle G. 1969; Autogenous and virus-induced interferons from lines of lymphoblastoid cells. Cancer Research 29:1467–1475
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-4-837
Loading
/content/journal/jgv/10.1099/0022-1317-65-4-837
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error